Vonova.io

Vonova is pioneering a transvascular platform to revolutionize brain access by using the venous system, thereby avoiding the risks and invasiveness of traditional craniotomy. Founded in 2020 and based in San Francisco, the company's 'Cerebro Platform' is a guided neurovascular system designed to improve recovery times and expand treatment options for millions of patients with chronic neurological disorders. Having secured seed financing and recognition as a MedTech Innovator finalist, Vonova is positioned at the intersection of neuroscience and advanced device technology to address a significant unmet clinical need.

The Cerebro Platform: a minimally invasive neurovascular system that uses real-time imaging to navigate the body's venous system as a natural pathway to access the brain surface for diagnostic and therapeutic delivery, eliminating the need for invasive skull drilling.

Direct competition in transvenous brain surface access appears limited but emerging. Vonova faces potential competition from other neurotech startups and, longer-term, from large, established medtech companies with strong neurovascular divisions (e.g., Medtronic, Stryker) who could develop competing platforms.